Antigen News and Research

RSS
How well does the BNT162b2 vaccine protect children and teens against Omicron?

How well does the BNT162b2 vaccine protect children and teens against Omicron?

4 Apr 2022
Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

1 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

1 Apr 2022
No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

31 Mar 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

31 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

30 Mar 2022
Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

30 Mar 2022
Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

30 Mar 2022
The potential efficacy of nasal nanoparticle COVID-19 vaccines

The potential efficacy of nasal nanoparticle COVID-19 vaccines

30 Mar 2022
Novel sensor could revolutionize COVID-19 virus testing

Novel sensor could revolutionize COVID-19 virus testing

30 Mar 2022
A ferritin nanoparticle candidate vaccine for COVID

A ferritin nanoparticle candidate vaccine for COVID

30 Mar 2022
Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

29 Mar 2022
Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

29 Mar 2022
Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

29 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback